Alector Announces Pricing of Initial Public Offering
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Feb 6, 2019--Alector, Inc. (Nasdaq: ALEC), a clinical stage biotechnology company pioneering immuno-neurology, a novel therapeutic app…
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Feb 6, 2019--Alector, Inc. (Nasdaq: ALEC), a clinical stage biotechnology company pioneering immuno-neurology, a novel therapeutic app…